The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toripalimab (anti-PD-1) plus recombinant human endostatin as adjuvant therapy in patients with resected stage III melanoma: Interim analysis of an open-label phase II trial.
 
Xianglin Hu
No Relationships to Disclose
 
Yu Xu
No Relationships to Disclose
 
Yang-bai Sun
No Relationships to Disclose
 
Ling-ge Yang
No Relationships to Disclose
 
Bi-qiang Zheng
No Relationships to Disclose
 
Zheng-Wang Sun
No Relationships to Disclose
 
Yong Chen
No Relationships to Disclose
 
Wangjun Yan
No Relationships to Disclose
 
Chun-Meng Wang
No Relationships to Disclose